Scholarly Index
Inga Marie Nilsson
Novartis (United States); 10,912 total citations; 274 total publications; best world rank #20
Novartis (United States)
10,912Total citations
274Total publications
54H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Enzyme Production and Characterization | Lifetime | 173 | US 37 | 98.76 |
| Hemophilia Treatment and Research | Lifetime | 51 | US 21 | 98.92 |
| Hemostasis and retained surgical items | Lifetime | 20 | US 9 | 98.47 |
| Platelet Disorders and Treatments | Lifetime | 228 | US 92 | 98.45 |
| Blood properties and coagulation | Lifetime | 154 | US 90 | 98.18 |
| Blood Coagulation and Thrombosis Mechanisms | Lifetime | 225 | US 87 | 98.26 |
| Blood disorders and treatments | Lifetime | 232 | US 94 | 97.14 |
| Oral and gingival health research | Lifetime | 218 | US 69 | 97.04 |
| Coagulation, Bradykinin, Polyphosphates, and Angioedema | Lifetime | 498 | US 194 | 96.34 |
| Blood groups and transfusion | Lifetime | 710 | US 320 | 96.12 |
| Protease and Inhibitor Mechanisms | Lifetime | 760 | US 319 | 95.88 |
| Myeloproliferative Neoplasms: Diagnosis and Treatment | Lifetime | 757 | US 305 | 95.00 |
| Heparin-Induced Thrombocytopenia and Thrombosis | Lifetime | 292 | US 112 | 94.62 |